decisionhealth Newsletters, Part B News - 2005 Issue 10 (October)
In-office chemo use up in 2004
Subscribe or sign in to view the full article.
Article Overview
This article summarizes Medicare policy and utilization trends affecting office-based chemotherapy in 2004, including changes tied to revised drug reimbursement methodology and administration payments. It discusses MedPAC’s review of practice billing patterns, concerns about patient access, and practitioner views on evolving payment programs. The piece is aimed at readers tracking oncology reimbursement, Medicare payment policy, and office-based drug administration trends.
Why This Topic Matters
It helps coding and reimbursement professionals understand a period of Medicare chemotherapy payment transition and the broader policy issues affecting oncology practices.
What You Will Learn
- How Medicare payment changes affected office-based chemotherapy services in 2004
- What MedPAC was reviewing in relation to oncology drug reimbursement and access
- Why oncology practices were concerned about changing drug payment programs
- How shifts in drug pricing and newer therapies influenced overall expenses
Who Should Read This
- Medical coders
- Oncology billing staff
- Practice managers
- Reimbursement analysts
- Healthcare policy readers
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com